USA: 
Europe: 
Email: 
Consultation
| Catalog: | C0251T |
| Product Type: | Test kit |
| Tested parameter: | IgG |
| Sample type: | dried blood spots (DBS) |
| Sensitivity: | 94.4% |
| Specificity: | 99.6% |
| Analysis mode: | ELISA |
| Application: | COVID-19 |
1. Use spike protein domain S1 to detect anti-SARS-CoV-2 IgG antibodies.
2. Antigen includes receptor binding domain, which is the main target of neutralizing antibody
3. It has a good correlation with the neutralization test shown by external research.
4. Use dried blood spots (DBS) as an alternative sample material.
5. Fully automated.
6. CE mark and FDA-EUA approval.
Diagnostic Development
Follow Us -
Copyright © 2024 Creative Bioarray. All rights reserved.
